Attached files
| file | filename |
|---|---|
| EX-31.4 - EX-31.4 - PLUS THERAPEUTICS, INC. | d144057dex314.htm |
| 10-K/A - 10-K/A - PLUS THERAPEUTICS, INC. | d144057d10ka.htm |
EXHIBIT 31.3
Certification of Principal Executive Officer Pursuant to
Securities Exchange Act Rule 13a-14(a)
As Adopted Pursuant to
Section 302 of the Sarbanes-Oxley Act of 2002
I, Marc H. Hedrick, certify that:
| 1. | I have reviewed this Annual Report on Form 10-K of Plus Therapeutics, Inc.; and |
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
Date: February 26, 2021
| /s/ Marc H. Hedrick, MD |
| Marc. H. Hedrick |
| President & Chief Executive Officer |